# KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

> **NCT03927495** · PHASE2 · UNKNOWN · sponsor: **Shanghai Chest Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma

## Interventions

- **DRUG:** KN046
- **RADIATION:** palliative radiotherapy
- **DRUG:** KN046

## Key facts

- **NCT ID:** NCT03927495
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-22
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03927495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03927495, "KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT03927495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*